{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T19:14:44Z","timestamp":1793733284588,"version":"4.6.1"},"reference-count":46,"publisher":"American Society of Hematology","issue":"17","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,4,27]]},"abstract":"<jats:title>Key Points<\/jats:title>\n               <jats:p>Single-cell gene expression analysis reveals CML stem cell heterogeneity and changes imposed by TKI therapy. A subpopulation with primitive, quiescent signature and increased survival to therapy can be high-purity captured as CD45RA\u2212cKIT\u2212CD26+.<\/jats:p>","DOI":"10.1182\/blood-2016-07-728873","type":"journal-article","created":{"date-parts":[[2017,1,25]],"date-time":"2017-01-25T22:00:41Z","timestamp":1485381641000},"page":"2384-2394","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":134,"title":["Single-cell molecular analysis defines therapy response and immunophenotype of stem cell subpopulations in CML"],"prefix":"10.1182","volume":"129","author":[{"given":"Rebecca","family":"Warfvinge","sequence":"first","affiliation":[{"name":"Division of Molecular Hematology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Geironson","sequence":"additional","affiliation":[{"name":"Division of Molecular Hematology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2581-5543","authenticated-orcid":false,"given":"Mikael N. E.","family":"Sommarin","sequence":"additional","affiliation":[{"name":"Division of Molecular Hematology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Lang","sequence":"additional","affiliation":[{"name":"Division of Molecular Hematology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Karlsson","sequence":"additional","affiliation":[{"name":"Division of Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Lund, Sweden;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teona","family":"Roschupkina","sequence":"additional","affiliation":[{"name":"Division of Molecular Hematology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leif","family":"Stenke","sequence":"additional","affiliation":[{"name":"Department of Hematology, Karolinska University Hospital, Stockholm, Sweden;"},{"name":"Department of Medicine, Karolinska Institutet, Stockholm, Sweden;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper","family":"Stentoft","sequence":"additional","affiliation":[{"name":"Department of Hematology, Aarhus University Hospital, Aarhus, Denmark;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulla","family":"Olsson-Str\u00f6mberg","sequence":"additional","affiliation":[{"name":"Department of Medical Science, and"},{"name":"Division of Hematology, University Hospital, Uppsala, Sweden;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Hjorth-Hansen","sequence":"additional","affiliation":[{"name":"Department of Hematology, St. Olavs Hospital, Trondheim, Norway;"},{"name":"Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satu","family":"Mustjoki","sequence":"additional","affiliation":[{"name":"Hematology Research Unit Helsinki and Department of Clinical Chemistry, University of Helsinki, Helsinki, Finland;"},{"name":"Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamit","family":"Soneji","sequence":"additional","affiliation":[{"name":"Division of Molecular Hematology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Richter","sequence":"additional","affiliation":[{"name":"Division of Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Lund, Sweden;"},{"name":"Department of Hematology, Oncology and Radiation Physics, Sk\u00e5ne University Hospital, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6ran","family":"Karlsson","sequence":"additional","affiliation":[{"name":"Division of Molecular Hematology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"5894","key":"2019111904404821100_B1","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/300765a0","article-title":"A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia","volume":"300","author":"de Klein","year":"1982","journal-title":"Nature"},{"issue":"5486","key":"2019111904404821100_B2","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1126\/science.289.5486.1938","article-title":"Structural mechanism for STI-571 inhibition of Abelson tyrosine kinase","volume":"289","author":"Schindler","year":"2000","journal-title":"Science"},{"issue":"11","key":"2019111904404821100_B3","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1056\/NEJMoa022457","article-title":"Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia","volume":"348","author":"O\u2019Brien","year":"2003","journal-title":"N Engl J Med"},{"issue":"5405","key":"2019111904404821100_B4","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/243290a0","article-title":"Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining","volume":"243","author":"Rowley","year":"1973","journal-title":"Nature"},{"issue":"11","key":"2019111904404821100_B5","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S1470-2045(10)70233-3","article-title":"Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial","volume":"11","author":"Mahon","year":"2010","journal-title":"Lancet Oncol"},{"issue":"1","key":"2019111904404821100_B6","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1182\/blood.V99.1.319","article-title":"Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro","volume":"99","author":"Graham","year":"2002","journal-title":"Blood"},{"issue":"11","key":"2019111904404821100_B7","doi-asserted-by":"crossref","first-page":"4532","DOI":"10.1182\/blood-2005-07-2947","article-title":"Dasatinib (BMS-354825) targets an earlier progenitor population than imatinib in primary CML but does not eliminate the quiescent fraction","volume":"107","author":"Copland","year":"2006","journal-title":"Blood"},{"issue":"6","key":"2019111904404821100_B8","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1182\/blood-2010-12-326843","article-title":"Chronic myeloid leukemia stem cells are not dependent on Bcr-Abl kinase activity for their survival","volume":"119","author":"Hamilton","year":"2012","journal-title":"Blood"},{"issue":"1","key":"2019111904404821100_B9","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1172\/JCI35721","article-title":"Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity","volume":"121","author":"Corbin","year":"2011","journal-title":"J Clin Invest"},{"issue":"7","key":"2019111904404821100_B10","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nm0797-730","article-title":"Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell","volume":"3","author":"Bonnet","year":"1997","journal-title":"Nat Med"},{"issue":"3","key":"2019111904404821100_B11","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/sj.leu.2403649","article-title":"Different subsets of primary chronic myeloid leukemia stem cells engraft immunodeficient mice and produce a model of the human disease","volume":"19","author":"Eisterer","year":"2005","journal-title":"Leukemia"},{"issue":"37","key":"2019111904404821100_B12","doi-asserted-by":"crossref","first-page":"16280","DOI":"10.1073\/pnas.1004408107","article-title":"Isolation and killing of candidate chronic myeloid leukemia stem cells by antibody targeting of IL-1 receptor accessory protein","volume":"107","author":"J\u00e4r\u00e5s","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"issue":"25","key":"2019111904404821100_B13","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1182\/blood-2013-10-536078","article-title":"Dipeptidylpeptidase IV (CD26) defines leukemic stem cells (LSC) in chronic myeloid leukemia","volume":"123","author":"Herrmann","year":"2014","journal-title":"Blood"},{"issue":"2","key":"2019111904404821100_B14","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3324\/haematol.2010.035006","article-title":"CD34(+)\/CD38(-) stem cells in chronic myeloid leukemia express Siglec-3 (CD33) and are responsive to the CD33-targeting drug gemtuzumab\/ozogamicin","volume":"97","author":"Herrmann","year":"2012","journal-title":"Haematologica"},{"issue":"16","key":"2019111904404821100_B15","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1182\/blood-2013-07-517847","article-title":"The IL-2\/CD25 axis maintains distinct subsets of chronic myeloid leukemia-initiating cells","volume":"123","author":"Kobayashi","year":"2014","journal-title":"Blood"},{"issue":"8","key":"2019111904404821100_B16","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1182\/blood-2012-12-475194","article-title":"Monoclonal antibody targeting of IL-3 receptor \u03b1 with CSL362 effectively depletes CML progenitor and stem cells","volume":"123","author":"Nievergall","year":"2014","journal-title":"Blood"},{"issue":"4","key":"2019111904404821100_B17","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.stem.2013.07.017","article-title":"Mapping cellular hierarchy by single-cell analysis of the cell surface repertoire","volume":"13","author":"Guo","year":"2013","journal-title":"Cell Stem Cell"},{"issue":"4","key":"2019111904404821100_B18","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.celrep.2013.07.020","article-title":"The tetraspanin CD9 affords high-purity capture of all murine hematopoietic stem cells","volume":"4","author":"Karlsson","year":"2013","journal-title":"Cell Reports"},{"key":"2019111904404821100_B19","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13059-016-0939-7","article-title":"Single-cell profiling of human megakaryocyte-erythroid progenitors identifies distinct megakaryocyte and erythroid differentiation pathways","volume":"17","author":"Psaila","year":"2016","journal-title":"Genome Biol"},{"issue":"6","key":"2019111904404821100_B20","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1084\/jem.20152013","article-title":"Single-cell transcriptional analysis of normal, aberrant, and malignant hematopoiesis in zebrafish","volume":"213","author":"Moore","year":"2016","journal-title":"J Exp Med"},{"issue":"6","key":"2019111904404821100_B21","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/ni.3412","article-title":"Distinct myeloid progenitor-differentiation pathways identified through single-cell RNA sequencing","volume":"17","author":"Drissen","year":"2016","journal-title":"Nat Immunol"},{"issue":"4","key":"2019111904404821100_B22","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.celrep.2015.12.082","article-title":"Single-cell RNA-sequencing reveals a continuous spectrum of differentiation in hematopoietic cells","volume":"14","author":"Macaulay","year":"2016","journal-title":"Cell Reports"},{"issue":"7","key":"2019111904404821100_B23","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/j.cell.2015.11.013","article-title":"Transcriptional heterogeneity and lineage commitment in myeloid progenitors [published correction appears in Cell. 2016;164(1-2):325]","volume":"163","author":"Paul","year":"2015","journal-title":"Cell"},{"issue":"3","key":"2019111904404821100_B24","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/ncb2442","article-title":"Inferring rules of lineage commitment in haematopoiesis","volume":"14","author":"Pina","year":"2012","journal-title":"Nat Cell Biol"},{"key":"2019111904404821100_B25","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1186\/s12859-015-0757-z","article-title":"SCExV: a webtool for the analysis and visualisation of single cell qRT-PCR data","volume":"16","author":"Lang","year":"2015","journal-title":"BMC Bioinformatics"},{"issue":"4","key":"2019111904404821100_B26","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/modpathol.3800322","article-title":"Tumor classification by tissue microarray profiling: random forest clustering applied to renal cell carcinoma","volume":"18","author":"Shi","year":"2005","journal-title":"Mod Pathol"},{"issue":"6","key":"2019111904404821100_B27","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.stem.2010.11.014","article-title":"TIM-3 is a promising target to selectively kill acute myeloid leukemia stem cells","volume":"7","author":"Kikushige","year":"2010","journal-title":"Cell Stem Cell"},{"issue":"17","key":"2019111904404821100_B28","doi-asserted-by":"crossref","first-page":"17ra9","DOI":"10.1126\/scitranslmed.3000349","article-title":"Identification of therapeutic targets for quiescent, chemotherapy-resistant human leukemia stem cells","volume":"2","author":"Saito","year":"2010","journal-title":"Sci Transl Med"},{"issue":"D1","key":"2019111904404821100_B29","doi-asserted-by":"crossref","first-page":"D1034","DOI":"10.1093\/nar\/gks1021","article-title":"HemaExplorer: a database of mRNA expression profiles in normal and malignant haematopoiesis","volume":"41","author":"Bagger","year":"2013","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"2019111904404821100_B30","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1038\/leu.2013.19","article-title":"Impact of malignant stem cell burden on therapy outcome in newly diagnosed chronic myeloid leukemia patients","volume":"27","author":"Mustjoki","year":"2013","journal-title":"Leukemia"},{"issue":"6","key":"2019111904404821100_B31","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.stem.2007.10.001","article-title":"Identification of a hierarchy of multipotent hematopoietic progenitors in human cord blood","volume":"1","author":"Majeti","year":"2007","journal-title":"Cell Stem Cell"},{"issue":"1","key":"2019111904404821100_B32","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/leu.2015.135","article-title":"IL1RAP expression as a measure of leukemic stem cell burden at diagnosis of chronic myeloid leukemia predicts therapy outcome","volume":"30","author":"Landberg","year":"2016","journal-title":"Leukemia"},{"issue":"7607","key":"2019111904404821100_B33","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nature18288","article-title":"Dual targeting of p53 and c-MYC selectively eliminates leukaemic stem cells","volume":"534","author":"Abraham","year":"2016","journal-title":"Nature"},{"issue":"7569","key":"2019111904404821100_B34","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nature15248","article-title":"Erosion of the chronic myeloid leukaemia stem cell pool by PPAR\u03b3 agonists","volume":"525","author":"Prost","year":"2015","journal-title":"Nature"},{"issue":"6","key":"2019111904404821100_B35","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1182\/blood.V94.6.2056","article-title":"Isolation of a highly quiescent subpopulation of primitive leukemic cells in chronic myeloid leukemia","volume":"94","author":"Holyoake","year":"1999","journal-title":"Blood"},{"issue":"4","key":"2019111904404821100_B36","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.devcel.2010.02.012","article-title":"Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst","volume":"18","author":"Guo","year":"2010","journal-title":"Dev Cell"},{"issue":"26","key":"2019111904404821100_B37","doi-asserted-by":"crossref","first-page":"9194","DOI":"10.1073\/pnas.0503280102","article-title":"Cell intrinsic alterations underlie hematopoietic stem cell aging","volume":"102","author":"Rossi","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"2019111904404821100_B38","doi-asserted-by":"crossref","first-page":"5553","DOI":"10.1182\/blood-2007-11-123547","article-title":"A new mechanism for the aging of hematopoietic stem cells: aging changes the clonal composition of the stem cell compartment but not individual stem cells","volume":"111","author":"Cho","year":"2008","journal-title":"Blood"},{"issue":"16","key":"2019111904404821100_B39","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1182\/blood-2009-04-215376","article-title":"BCR-ABL enhances differentiation of long-term repopulating hematopoietic stem cells","volume":"115","author":"Schemionek","year":"2010","journal-title":"Blood"},{"issue":"5","key":"2019111904404821100_B40","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s00432-015-2101-4","article-title":"Assessment of bone marrow lymphocytic status during tyrosine kinase inhibitor therapy and its relation to therapy response in chronic myeloid leukaemia","volume":"142","author":"El Missiry","year":"2016","journal-title":"J Cancer Res Clin Oncol"},{"issue":"12","key":"2019111904404821100_B41","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1016\/j.celrep.2016.02.073","article-title":"Mitotic history reveals distinct stem cell populations and their contributions to hematopoiesis","volume":"14","author":"S\u00e4w\u00e9n","year":"2016","journal-title":"Cell Reports"},{"issue":"8","key":"2019111904404821100_B42","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1182\/blood-2016-05-716480","article-title":"A single-cell resolution map of mouse hematopoietic stem and progenitor cell differentiation","volume":"128","author":"Nestorowa","year":"2016","journal-title":"Blood"},{"issue":"3","key":"2019111904404821100_B43","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1182\/blood.V97.3.720","article-title":"Primitive quiescent leukemic cells from patients with chronic myeloid leukemia spontaneously initiate factor-independent growth in vitro in association with up-regulation of expression of interleukin-3","volume":"97","author":"Holyoake","year":"2001","journal-title":"Blood"},{"issue":"18","key":"2019111904404821100_B44","doi-asserted-by":"crossref","first-page":"5775","DOI":"10.1158\/0008-5472.CAN-13-1318","article-title":"KIT signaling governs differential sensitivity of mature and primitive CML progenitors to tyrosine kinase inhibitors","volume":"73","author":"Corbin","year":"2013","journal-title":"Cancer Res"},{"issue":"11","key":"2019111904404821100_B45","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1002\/stem.721","article-title":"Low level of c-kit expression marks deeply quiescent murine hematopoietic stem cells","volume":"29","author":"Matsuoka","year":"2011","journal-title":"Stem Cells"},{"issue":"21","key":"2019111904404821100_B46","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1038\/sj.onc.1205317","article-title":"Tyrosine kinase oncogenes in normal hematopoiesis and hematological disease","volume":"21","author":"Scheijen","year":"2002","journal-title":"Oncogene"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/129\/17\/2384\/1400266\/blood728873.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/129\/17\/2384\/1400266\/blood728873.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T04:41:10Z","timestamp":1574138470000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/129\/17\/2384\/35973\/Singlecell-molecular-analysis-defines-therapy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,27]]},"references-count":46,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2017,4,27]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2016-07-728873","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,27]]}}}